03.05.2023 - 95% success rate of reaching pre-determined vascular target with no intraoperative complications presented during pre-clinical studiesHINGHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) - Microbot Medical Inc. (Nasdaq: MBOT), the developer of the ...